Chiron Investment Management’s Bio-Techne TECH Stock Holding History

Chiron Investment Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,068	Closed	-$145K	–	86
2020 Q1	$145K	Hold	3,068	–	–	0.03%	50
2019 Q4	$168K	Sell	3,068 -800	-21%	-$42K	0.02%	49
2019 Q3	$189K	Hold	3,868	–	–	0.03%	44
2019 Q2	$202K	Sell	3,868 -400	-9%	-$20.2K	0.04%	35
2019 Q1	$212K	Sell	4,268 -1,600	-27%	-$72K	0.04%	28
2018 Q4	$212K	Buy	5,868 +2,800	+91%	+$117K	0.03%	33
2018 Q3	$157K	Sell	3,068 -3,876	-56%	-$172K	0.01%	61
2018 Q2	$257K	Buy	6,944 +3,504	+102%	+$134K	0.02%	47
2018 Q1	$130K	Buy	+3,440	New	+$122K	0.01%	45

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Chiron Investment Management's TECH Position: Q2 2020 in Review

Chiron Investment Management sold out of Bio-Techne (TECH) in Q2 2020, closing a stake of 3,068 shares — an estimated $145K sold.

Chiron Investment Management first reported a position in TECH in Q1 2018 and held it in 9 quarters. The position peaked at $257K in Q2 2018. 393 funds tracked by Wall St. Rank hold TECH as of Q2 2020.

Chiron Investment Management reported no remaining Bio-Techne position as of Q2 2020 after selling out during the quarter.
Chiron Investment Management sold 3,068 Bio-Techne shares in Q2 2020, an estimated $145K.
Chiron Investment Management first reported a position in Bio-Techne in Q1 2018 and held it in 9 quarters.
Chiron Investment Management's Bio-Techne position peaked at $257K in Q2 2018.
393 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2020.

Based on Chiron Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.